Discovery of new [Formula: see text] proteasome inhibitors using a knowledge-based computational screening approach (Q35732424)

9 August 2017

title

Discovery of new [Formula: see text] proteasome inhibitors using a knowledge-based computational screening approach (English)

1 reference

9 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Reena Chib

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Gurunadham Munagala

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Kushalava Reddy Yempalla

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Inshad Ali Khan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Parvinder Pal Singh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Farrah Gul Khan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Amit Nargotra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

publication date

1 August 2015

1 reference

9 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

page(s)

1003-1019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

The Mycobacterium tuberculosis proteasome: more than just a barrel-shaped protease

15 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Genes required for mycobacterial growth defined by high density mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Fellutamide B is a potent inhibitor of the Mycobacterium tuberculosis proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Inhibitors selective for mycobacterial versus human proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Distinct specificities of Mycobacterium tuberculosis and mammalian proteasomes for N-acetyl tripeptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

N,C-Capped dipeptides with selectivity for mycobacterial proteasome over human proteasomes: role of S3 and S1 binding pockets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

3H-1,2,4-Dithiazol-3-one compounds as novel potential affordable antitubercular agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Identification and optimization of Escherichia coli GlmU inhibitors: an in silico approach with validation thereof.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Do structurally similar molecules have similar biological activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Identification of potent EGFR inhibitors from TCM Database@Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

2D QSAR consensus prediction for high-throughput virtual screening. An application to COX-2 inhibition modeling and screening of the NCI database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Pharmacophore-based screening and identification of novel human ligase I inhibitors with potential anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase 2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Pharmacophore modeling of nilotinib as an inhibitor of ATP-binding cassette drug transporters and BCR-ABL kinase using a three-dimensional quantitative structure-activity relationship approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Three-dimensional pharmacophore methods in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Proteasome inhibitors: Dozens of molecules and still counting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Proteasome inhibitors: an expanding army attacking a unique target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Synthesis and pharmacology of proteasome inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Covalent and non-covalent reversible proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Non-covalent proteasome inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9624-0

Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26232029

12 December 2020

inferred from PubMed ID database lookup

PHASE: a novel approach to pharmacophore modeling and 3D database searching

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26232029

12 December 2020

inferred from PubMed ID database lookup

A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26232029

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11030-015-9624-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json

release_tnwpqqfy35dsdklk6s5almwqoi

15 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tnwpqqfy35dsdklk6s5almwqoi

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26232029%20AND%20SRC:MED&resulttype=core&format=json